with the High Sponsorship of CPLP
Journal DOI: 10.19277/bbr
The Biomedical and Biopharmaceutical Research / Investigação Biomédica e Biofarmacêutica (BBR/IBB) is a peer-reviewed, bilingual, international scientific publication created primarily to foster societal progress through health-related knowledge within the Portuguese speaking countries around the world. BBR is distinguished with the High Sponsorship of CPLP (Community of Portuguese Speaking Countries). It is owned by ALIES, a non-profit organisation (read more about ALIES here)
Health is critical for progress, and among the countries which share the Portuguese language and culture, this progress is not uniform. BBR/IBB offers the opportunity to address specific issues in these communities, by its own observers, with a permanent translational purpose to improve education and societal advancement. However, BBR/IBB is not exclusively for Portuguese speaking authors, and many of the challenges faced within the lusofone universe are shared with the rest of the world. We believe our views, experiences, and achievements – including the Portuguese speaking diaspora spread all over the world – can positively impact the world at large.
Within the fields of biomedical and biopharmaceutical sciences, the research interests of BBR/IBB are focused on environmental, social, behavioural, technological and political perspectives to promote human health and prevent disease in the individual and their communities.
BBR is an independent open-access publication, free for readers, focused in high quality research, promoting diversity, equity and equality , and guided by the highest ethical standards in human medical research.
BBR/IBB scope reflects a fundamental / integrative research character, serving as a platform for knowledge exchange by publishing original papers, reviews, and case reports. BBR is focused in, but not limited to, the following subjects
- Behavior, Lifestyles & Wellness
- Nutrition and Food Sciences
- Pharmacology, Therapeutics and Toxicology
- Pharmacotechnology and Nanotechnology
- Physiology or Medicine
- Hygiene, Health & Digital Innovation
- Medicinal Chemistry and Natural Products
- Technology, Sensors and Methods of Analysis
At the Editor’s discretion, research on more applied topics may be included.
BBR/IBB seeks to promote the application of research into practice and especially values open collaborative cross-disciplinary science. BBR welcomes papers with translational potential in biomedicine and biopharmaceutics issues, seeking research with a focus in new perceptions on structural issues impacting health policies and systems, new molecules (natural or designed) with potential to address main disease burdens, or new mechanistic insights into models or processes to study disease mechanisms with potential impact in diagnostic and/or therapeutics.
Editors do not receive any salary for their work at BBR. Even so, Editors are required to declare all relevant competing interests and are excluded from participation in the review of any submission for which they have a competing interest.
BBR/IBB does not charge costs or fees for submission and publication of manuscripts from Portuguese-language speaking authors. For other authors, only an English version is required for submission. However, BBR/IBB does not accept automatic translations (GoogleTranslate, DeepL, other) meaning that the Portuguese version will be a direct responsibility of the Editorial Office. In this case, a fee will be charged to ensure that purpose [ + here ].
Indexing and Archiving
BBR/IBB is present in several databases - Portuguese Medical Journals, SciElo UNIVERSIA - Portal das Universidades, LATINDEX, KOSMET Index, Thomson Reuters, PMC, , Index Copernicus, Scopus, Google Scholar, REDIB, and mEDRA, among others.
Application to other databases is in progress.
Check publishing details including ISSN and publication quartiles for BBR/IBB [ + here ].
Ethics and Good Publication Practices
BBR/IBB takes very seriously all its duties and ethical responsibilities regarding all stages of publication. Our editorial options and policies are detailed [ + here ].
BBR/IBB is continuously working to promote diversity a concern addressed by a constant (not always well succeeded) search for authors and editors from minor or in-developing communities within the “lusofone” countries. The same awareness has shaped the expansion of our editorial board equity and equality (gender, religious, social, cultural, racial). Our publication priorities and decisions are made keeping in mind the quality, originality and utility of the submitted manuscripts. Nevertheless, we are aware that more inclusive policies are needed to modify recognised imbalances in biomedical publications.
ALIES is a non-profit open access publisher supporting all researchers, with emphasis on those from Portuguese speaking countries and communities, to use biomedical and biopharmaceutical knowledge published in BBR/IBB for social progress and science dissemination.
Reproduction rights and publication
BBR journal is an open access publisher that adopts the CC BY-NC (Creative commons) distribution license [see more here] and all articles are immediately and permanently accessible online free of charge and whithout any type of registration.
Visit BBR Contact page for details [+here].